Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Piramal Pharma Limited ( (IN:PPLPHARMA) ) has provided an announcement.
Piramal Pharma Limited announced the approval of a resolution to appoint Ms. Nathalie Leitch as a Non-Executive, Non-Independent Director following a postal ballot and remote e-voting process. The resolution was passed with the requisite majority, reflecting shareholder support and potentially strengthening the company’s governance structure.
More about Piramal Pharma Limited
Piramal Pharma Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of pharmaceutical products. The company provides a range of services and products, including critical care, consumer products, and contract development and manufacturing services, catering to a global market.
YTD Price Performance: -15.36%
Average Trading Volume: 382,791
Current Market Cap: 282.1B INR
For a thorough assessment of PPLPHARMA stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money